Can mere light become a revolutionary new treatment for traumatic brain injury, posttraumatic stress disorder, depression, stroke, Parkinson disease, and Alzheimer disease?

The COVID-19 epidemic has underscored potential gaps in mental health services during emergencies, while also testing the resilience of healthcare workers and medical systems.

A new guideline from AAN offers recommendations on the use of behavioral, nutraceutical, and complementary and alternative medicine (CAM) for improving sleep disorders in children with ASD.

Responses to treatment depend on the target chosen, with 5 targets yielding positive outcomes, including the ventral anterior limb of the internal capsule, subthalamic nucleus, nucleus accumbens, ventral capsule/ventral striatum, or inferior thalamic peduncle, all involving fronto-striato-thalamocortical circuits.

Largely understudied until recently, Functional Neurological Disorder presents a critical challenge to practitioners in neurology and psychiatry.

Hearing loss is associated with higher levels of anxiety, interpersonal sensitivity, and hostility, as well as higher rates of dementia, especially in older adults who are also visually impaired.

This newly established center at Johns Hopkins is reinvigorating research on the potential therapeutic applications of psychedelics.

Although compensating for their difficulties may help people with ASD connect with others, get jobs, and successfully navigate social situations, accumulating research suggests it can also lead to exhaustion, burnout, anxiety, and depression.

Depression is one of the most commonly reported complications resulting from stroke.

Combat veterans face an elevated risk of developing PTSD and comorbid depression, which severely affects quality of life.

Could a proposal by an expert panel undermine years of progress made in the identification and intervention of autism?

While new technology is making it more accessible, the clinical applications of genome sequencing are still being explored.

Omega-3 fatty acids, melatonin, and digestive enzymes are being investigated as potential treatments.